Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Collaborations
8/25/26
Espoir Biosciences and TransBIOTech Receive a $450,000 Grant
This funding will support the preclinical development of a potential new treatment targeting a key pathway involved in the nerve damage associated with amyotrophic lateral sclerosis (ALS).
Awards
June 17, 2026
Finalists for the Impact, Innovation and Applied Research Award
TransBIOTech, in partnership with 9bio Therapeutics, are finalists for the ADRIQ Impact, Innovation and Applied Research Award.
Publications & Expertise
April 15, 2026
Scientific Presentation
Poster presented by Carole-Ann Huppé, PhD, MBA, pharmacology researcher, at the annual conference of the Canadian Thoracic Society in Calgary (AB) on April 16-18, 2026
